Clinical data have shown that an abnormal increase in the phosphorylation level of Tf in the brains of AD patients is associated with decreased iron-binding capacity, leading to an increase in free iron levels in the brain, the production of large amounts of ROS, and the onset of oxidative stress (Ashraf et al., 2020). Here, TF is linked to Alzheimer disease.